Home | Services & Solutions | Drug Product | Oral | Manufacturing

WuXi STA has been manufacturing clinical trial materials (CTM) since 2008, supplying thousands of batches to USA, UK, EU, China, Japan, Korea, Australia, New Zeal and Thailand. Currently we are producing 8 commercial drug products to all major markets.  

In 2023 alone, we have delivered over 2,500 batches. 

We have multiple manufacturing plants allowing for parallel production to accelerate time sensitive supplies. Specifically, we also have the manufacturing facilities for high potency oral drug product at Wuxi City site. All facilities across China, Europe and the US share the same global standard, approved by all major regulatory agencies.

Manufacturing Platform

Blending
Roller Compaction
Wet Granulation
(high shear & fluidised bed)
Compression
Pelletisation
(extrusion & spheronisation)
Coating
Encapsulation
Continuous Manufacturing

High Potency Oral Drug

We have established high potency oral solid dosage manufacturing facilities in Wuxi City.  The Wuxi City site supports high potency oral drugs with formulation development services and drug product manufacturing services with our consistent global high standards.

Our high potency oral drug manufacturing plants feature a fully enclosed production system with automated equipment. Its Containment Performance Target (CPT) meets the control requirements of Occupational Exposure Limit (OEL) as low as 10 ng/m3. We offer one-stop formulation services, including wet and dry granulation, capsule filling, tablet compression, and coating. Our production capacity is 600 million doses.

WuXi STA Launches First Continuous Manufacturing Line for Oral Solids Manufacturing

Continuous Manufacturing

WuXi STA has a state-of-the-art drug product continuous manufacturing (CM) line for oral solids in Wuxi City site, China. It features continuous direct compression equipment with unit operations including dispensing, blending, lubrication, tablet compression, and coating.

The equipment design complies with the global GMP regulations. Process Analytical Technology (PAT) is implemented within the CM line to monitor blending uniformity, allowing for real-time analysis and control during production to ensure high quality.

Packaging & Labeling

At WuXi STA, we understand the need for flexibility at the early stages of clinical testing, the effective dose, stability and compliance. Our packaging & labeling teams will work with you to collect the relevant data and test various packaging options as your compounds progresses. Packages can be designed to protect from humidity, light and adulteration to ensure high quality. We can manufacture placebo and over-encapsulation for blinding purpose.

Please refer to our Clinical Supply Service webpage for further storage and distribution services.  

primary packaging img Manufacturing
Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes